I ntramedullary spinal cord gliomas are relatively rare lesions, accounting for approximately 20%-25% of all primary spinal cord tumors. 2, 4 Of this small population of patients with intramedullary gliomas, only 7.5%-17% have high-grade lesions, a percentage that varies according to the type of glioma and the age of the patient. 2, 4, 18 Unfortunately, much like high-grade gliomas of the brain, high-grade gliomas of the spinal cord are associated with a dismal prognosis, one that may also be worse for lesions in the thoracic spine. 2, 6, 18 Moreover, there is no consensus regarding their treatment.
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In general, treatment often consists of surgical debulking followed by radiation therapy and, occasionally, chemotherapy. Cordectomy is used infrequently, for, despite its potential utility, there are substantial associated risks with unproven benefits, since high-grade lesions are believed to be incurable. Thus, there has been only a handful of reported cases in which cordectomy has been employed for spinal neoplasms. 1, 7, 9, 14, 15, 21, 25 Here, we present the case of a 9-year-old boy who underwent cordectomy for the treatment of a high-grade spinal glioma. The patient has been disease free in the 14 years since his diagnosis and in the 13 years since undergoing cordectomy.
case report

Presentation
This 9-year-old boy originally presented to medical attention in 2001 with a several-month history of a widebased swinging gait and difficulty running. MRI of the spinal cord revealed an enhancing intramedullary T9-12 mass that appeared consistent with a diffusely infiltrative astrocytoma (Fig. 1) .
Initial Operation and Histopathological Findings
After discussing the options with his family, the patient underwent T9-12 laminectomies and debulking of the tumor. Due to the infiltrative nature of the lesion, a gross-total resection was not attempted in an effort to spare normal spinal cord function. Electrophysiological neuromonitoring was performed using somatosensory and motor evoked potentials, and alteration of the former was observed at the time of the midline myelotomy. Pathology demonstrated a glioma composed of glial fibrillary acidic protein (GFAP)-immunoreactive cells with elongated processes and homogeneous oval nuclei. The tumor cells were arranged in a palisading-like fashion resembling a "polar spongioblastoma-like" arrangement. No Rosenthal fibers or hyaline droplets were observed. The tumor exhibited minimal cellular atypia and no necrosis or microvascular proliferation. Mitotic figures were rare, but the Ki 67 labeling index was mildly elevated. Though the tumor did not fit the typical appearance of a pilocytic astrocytoma, a diagnosis of low-grade astrocytoma was made (Fig. 2) .
Postoperative Course
The patient was able to ambulate short distances with the aid of orthotics and crutches. One month later, MRI revealed a mildly enhancing residual mass that extended from T-9 to the conus medullaris (Fig. 3) . Subsequently, the patient received a 1-month course of external-beam radiotherapy, with an overall dose of 3960 cGy in 22 treatment fractions utilizing a 3-field spinal technique.
Following radiotherapy, the patient returned to normal activity and regained the ability to participate in athletic activities. However, several months later he experienced acute-onset paraparesis, paresthesias, back pain, and spasms. MRI revealed progression of the lesion such that it was slightly increased in size from the original tumor. In addition, associated edema was noted to extend from the tumor caudally to the conus and rostrally to the level of C-5, leading to weakness in the upper extremities.
Second Operation and Histopathological Findings
After further discussion with the family, the patient underwent reoperation with internal debulking of the tumor while intraoperative electrophysiological neuromonitoring was performed. Pathology confirmed a fibrillary glioma with histopathological features similar to those seen in the previous biopsy sample. However, in this larger specimen, the tumor exhibited infiltration of the spinal cord parenchyma without a definitive tumor-spine parenchyma in- terface (Fig. 4) . Although the glioma infiltrated the parenchyma within the perivascular spaces, perivascular pseudorosettes were not observed. Unlike the previous biopsy sample, in this surgical specimen the tumor showed, in addition to areas of radiation necrosis, multifocal areas of palisading necrosis and microvascular proliferation. Mitotic activity and the Ki 67 labeling index were elevated. Similar to the previous biopsy sample, obvious features of a pilocytic astrocytoma including Rosenthal fibers and hyaline droplets were not observed. Because of the increased anaplastic features, we established a diagnosis of a high-grade astrocytoma, at least WHO Grade III. Postoperatively, the patient had substantially decreased strength bilaterally, with Grade 0/5 strength in both legs, and loss of proprioception and light touch below the T-8 level.
Second Postoperative Course
Two weeks after his second surgery, follow-up MRI revealed residual enhancement from T-9 to T-12, with significantly improved edema and no abnormal enhancement rostral to the tumor. Abnormal enhancement was also absent throughout the remainder of the craniospinal axis (Fig. 5) . In light of the increasingly aggressive nature of the tumor, as well as the absence of return of function inferior to the tumor, a cordectomy was recommended. The patient and his family were counseled regarding the expected permanent neurological deficits, and the absence of a proven benefit to the surgery, before they decided to proceed with a cordectomy for potentially definitive treatment of his high-grade lesion.
Third Operation
The patient was brought back to the operating room where he underwent T6-L1 laminectomies. In an attempt to achieve a wide margin of resection, an intraoperative biopsy was performed at the T-6 level, 3 levels above the radiographic extent of the lesion. Although a more rostral resection would have widened the surgical margin to known tumor, it was felt that stopping at T-6 would minimize the potential risk of resultant autonomic dysreflexia. Once the intraoperative biopsy demonstrated normal spinal cord with no evidence of tumor, the T-6 vertebra was selected as the rostral margin of the resection and a complete removal of the spinal cord from T-6 to the conus was performed, with transection of the accompanying exiting nerve roots. Pathology again was consistent with a highgrade astrocytoma (Fig. 6 ).
Third Postoperative Course
By postoperative Day 2, the patient was out of bed without difficulty and did not have any unexpected deficits. Postoperative MRI revealed complete removal of all abnormal spinal cord, and the patient was discharged to a rehabilitation facility on postoperative Day 3. No further adjuvant therapy was initiated.
Beginning 2 months after the cordectomy, the patient underwent serial MRI every 6 months for 3 years, followed by annual examinations, all of which showed no recurrence of his tumor. Approximately 2 years after surgery, the patient presented with paralytic kyphoscoliosis, which was treated with posterior instrumentation and T5-L4 fusion to correct his substantial deformity. This required reoperation 2 years later for extension of the fusion. MRI and radiography performed 8 years following his initial surgery demonstrated expected postoperative changes and failed to show evidence of a syrinx or enhancing lesions (Fig. 7) . Ultimately, the patient was able to resume athletic activity. He eventually received an athletic scholarship to the University of Illinois for wheelchair basketball and later was a member of the Under-23 US Men's National Wheelchair Basketball Team (Fig. 8) . He has been disease free for the last 13 years.
Reclassification of the Tumor
During the recent review of the pathological materials for preparation of this manuscript, a question of the precise diagnosis of the tumor was raised. The intense fibrillary nature and fascicular arrangements of this glioma, in conjunction with the lack of features suggesting a pilocytic astrocytoma, raised the possibility that the tumor might have been a tanycytic ependymoma, a rare variant of ependymoma that may exhibit histopathology features indistinguishable from pilocytic astrocytomas. 8, 12 This diagnosis was not entertained at the time of the initial resections (2001) (2002) . Additional immunohistochemical stains performed at this time demonstrated the tumor cells' lack of reactivity for the transcription factor Olig-2, a feature described in spinal cord ependymomas, 19 and the presence of dot-like epithelial membrane antigen positivity in the tumor cells. Therefore, despite the infiltrative nature of this glioma, we now believe that the tumor would be classified as an anaplastic tanycytic ependymoma, WHO Grade III.
discussion
We have presented the successful treatment option for a high-grade spinal cord glioma, describing a complete removal of the spinal cord, and its associated nerve roots, beginning approximately 2 levels above the level of the tumor. We feel that there are several aspects of this particular case that warrant further discussion; however, what is perhaps most remarkable is the infrequency with which this procedure is used.
While cordectomy has been advocated for a number of neurosurgical conditions, including intractable pain, spasticity, and syringomyelia, 5, 10, 13, 23, 24 there is little mention of its being performed in the setting of spinal cord tumors. In fact, to our knowledge, the literature contains only 7 reported cases in which cordectomy was used to treat spinal cord tumors, 1, 7, 9, 14, 15, 21, 25 none of which involved pediatric patients.
The first mention of using cordectomy to treat a spinal cord tumor was in 1949, when MacCarty and Kiefer 14 described performing it to treat a thoracic glioblastoma multiforme (GBM) in a 25-year-old man. Approximately 40 years later, a cordectomy for a spinal cord tumor was again described by Tokoro et al., 25 who performed the procedure for a recurrent neurinoma of the thoracic spine. While the lesion was not malignant, it had caused syringobulbia-myelia with resultant central sleep apnea, both of which resolved after surgery.
Later, in 2002, Kyoshima et al. 9 described their use of cordectomy for an anaplastic astrocytoma of the thoracolumbar spinal cord in a 48-year-old man. Similar to our patient, theirs had undergone multiple subtotal resections of a low-grade astrocytoma, and the patient eventually developed paraplegia. However, the cordectomy was not performed until roughly 2 years after the tumor had progressed to a malignant glioma, and the patient died of tumor recurrence and dissemination 15 months after the cordectomy. In 2005, Raza et al. 21 reported performing cordectomy in a 65-year-old patient with a recurrent atypical meningioma of the thoracic spine, although they were unable to achieve a total resection due to persistent meningeal involvement. Marchan et al. 15 performed cordectomy for a spinal GBM in a 50-year-old man. Approximately 3 months after establishing the diagnosis of spinal GBM and after the patient had become progressively paraplegic despite radiotherapy and chemotherapy, Marchan and colleagues opted to undertake a spinal cordectomy rather than debulk the lesion. The patient remained disease free for approximately 6 years before developing multiple cerebellar GBMs and dying shortly thereafter.
Most recently, Ewelt and associates reported on a 27-year-old woman with a recurrent T9-12 anaplastic astrocytoma treated by cordectomy. 7 The patient had previously undergone surgical debulking, radiation treatment, and temozolomide-based chemotherapy without successful eradication of the lesion. Subsequently, the patient developed paraplegia as a result of tumor progression. A cordectomy was ultimately performed between the T-8 and T-9 levels and no disease recurrence was seen up to 15 months postoperatively.
Regarding ependymomas, a large epidemiological study found that approximately 36% of ependymomas are located in the spine, but only 13% of pediatric ependymomas are spinal. 16 In addition, 8.6% of ependymomas were found to be Grade III. Oh et al. recently reviewed the literature on pediatric spinal cord ependymomas and, after excluding myxopapillary ependymomas, found a total of 58 cases for their analysis. 18 They indicated that 17% of the individuals in this group had Grade III lesions.
As previously stated, the prognosis for high-grade spinal gliomas is poor, and certainly the treatment options available for many of these infiltrative lesions are not ideal. While some advocate function-preserving subtotal resection followed by postoperative radiation therapy, or even radiation therapy alone, 17, 22 others feel that radiation therapy may be of limited value in children and therefore recommend radical resection despite the increased risk of neurological deficit. 2, 20 However, largely due to the relative infrequency of these lesions, no consensus exists regarding their management. Although our patient was initially diagnosed with a low-grade glioma, the infiltrative nature of the tumor and the elevated Ki 67 labeling index portended a more aggressive course. Therefore, after discussing further aggressive surgery, observation, or radiotherapy, the decision was made to proceed with adjuvant radiation following the patient's first surgery. Once the tumor worsened, radical surgery became a more reasonable option. While there have been few reports of cordectomy for highgrade gliomas of the spinal cord, we felt that our patient's preexisting paraplegia below the level of the tumor, combined with the worsening tumor grade, ultimately made him a good candidate for complete excision of the spinal cord above the lesion. In hindsight, we do not believe that our recent reclassification of his tumor as a WHO Grade III anaplastic tanycytic ependymoma would have changed our recommendations.
Another aspect of our patient's care that is worth mentioning is the development of kyphoscoliosis, a condition that is frequently seen as a consequence of extensive laminectomies, radiation therapy, or intramedullary tumor resection. 3, 11, 20, 22 Our patient underwent an 8-level decompression in addition to the spinal cord resection, which eventually required segmental instrumentation and fusion. Because of the increased risk for developing progressive spinal deformity in this patient population, patients should undergo long-term follow-up not just for the management of their tumor, but for observation for the development of deformity.
conclusions
We have provided further evidence that cordectomy is a viable option for patients with high-grade spinal cord gliomas, with the potential for cure of the disease. However, evidence demonstrating the success of the procedure is merely anecdotal. Therefore, given the lack of higher levels of evidence demonstrating its efficacy, we believe that complete resection of the spinal cord should likely only be considered for patients with poor neurological function and no evidence of tumor dissemination. It is in this select patient population that cordectomy may have a legitimate role for the management of high-grade spinal cord gliomas.
references
